ITPKB mutations are significantly overrepresented in DLBCL38,39, and in ITPKB−/− mice, B cell lymphomas develop with constitutive activation of PI3K signaling40. This evidence concerns the gene ITPKB and B-cell non-Hodgkin lymphoma.